Cytogenetic and clinical marks for defining high-risk myeloma in the context of bortezomib treatment

标题
Cytogenetic and clinical marks for defining high-risk myeloma in the context of bortezomib treatment
作者
关键词
-
出版物
EXPERIMENTAL HEMATOLOGY
Volume 43, Issue 3, Pages 168-176.e2
出版商
Elsevier BV
发表日期
2014-11-21
DOI
10.1016/j.exphem.2014.11.004

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started